Patents by Inventor Benjamin Winograd

Benjamin Winograd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230181534
    Abstract: The present disclosure is related to dosage strategies for the treatment of CNS cancers with proteasome inhibitors (e.g., marizomib). For instance, the disclosure is related to strategies in which a proteasome inhibitor (e.g., marizomib) is administered at the same or higher dosage even after a subject has experienced a CNS-related adverse event.
    Type: Application
    Filed: December 6, 2022
    Publication date: June 15, 2023
    Inventors: Mohit TRIKHA, Nancy LEVIN, Benjamin WINOGRAD
  • Publication number: 20200085789
    Abstract: The present disclosure is related to dosage strategies for the treatment of CNS cancers with proteasome inhibitors (e.g., marizomib). For instance, the disclosure is related to strategies in which a proteasome inhibitor (e.g., marizomib) is administered at the same or higher dosage even after a subject has experienced a CNS-related adverse event.
    Type: Application
    Filed: March 7, 2018
    Publication date: March 19, 2020
    Inventors: Mohit TRIKHA, Nancy LEVIN, Benjamin WINOGRAD
  • Publication number: 20090247598
    Abstract: There are disclosed methods for treating cancer in a patient in need of such treating comprising administering temozolomide according to improved dosing regimen and/or schedules based on the patient's MGMT level. Additional improved methods for treating patients with temozolomide are also disclosed.
    Type: Application
    Filed: February 25, 2009
    Publication date: October 1, 2009
    Inventors: CHEN ZONG, Benjamin Winograd
  • Publication number: 20060100188
    Abstract: There are disclosed methods for treating cancer in a patient in need of such treating comprising administering temozolomide according to improved dosing regimen and/or schedules based on the patient's MGMT level. Additional improved methods for treating patients with temozolomide are also disclosed.
    Type: Application
    Filed: November 7, 2005
    Publication date: May 11, 2006
    Inventors: Chen Zong, Benjamin Winograd